Valuation: Bio-Techne Corporation

Market Cap 11.16B 9.78B 9.04B 8.32B 15.7B 1,077B 15.95B 108B 42.39B 527B 41.92B 41B 1,815B P/E 2026 *
61.5x
P/E 2027 * 51.9x
Enterprise Value 11.1B 9.72B 8.99B 8.27B 15.6B 1,070B 15.85B 107B 42.13B 523B 41.66B 40.75B 1,804B EV / Sales 2026 *
9.18x
EV / Sales 2027 * 8.55x
Free-Float
99.69%
Yield 2026 *
0.45%
Yield 2027 * 0.45%

Last Transcript: Bio-Techne Corporation

1 day-0.67%
1 week+0.39%
Current month+1.40%
1 month+23.65%
3 months+18.26%
6 months+2.98%
Current year+21.82%
1 week 71.31
Extreme 71.31
72.12
1 month 55.46
Extreme 55.46
72.12
Current year 43.2
Extreme 43.195
72.16
1 year 43.2
Extreme 43.195
72.16
3 years 43.2
Extreme 43.195
89.83
5 years 43.2
Extreme 43.195
135.96
10 years 23.92
Extreme 23.92
135.96
Manager TitleAgeSince
Chief Executive Officer 59 01/02/2024
Director of Finance/CFO 55 01/04/2014
Chief Tech/Sci/R&D Officer - 06/08/2023
Director TitleAgeSince
Chairman 70 02/11/2012
Director/Board Member 56 19/05/2009
Director/Board Member 63 26/10/2017
Date Insider Type Main position Quantity % Market Cap.
2/6/26 Fiscal year

Executive/Senior Manager

1,416 0.0009%
8/5/26 Other

Director

19,908 0.0127%
5/5/26 Fiscal year

Chief Financial Officer

180,955 0.1157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%+0.39%+37.72%-17.58% 11.16B
-1.26%-4.33%-0.78%+13.51% 48.71B
-3.10%-1.94%+370.99%+572.60% 38.35B
-0.46%+2.18%+5.44%+61.01% 34.53B
-1.14%-1.76%+26.94%-9.93% 34.03B
-1.82%-1.43%+0.52%+31.85% 26.77B
-3.54%-5.08% - - 15.64B
-1.82%-0.43%+69.28%+113.82% 15.08B
-1.55%+1.54%+13.77%+14.66% 14.18B
-2.25%+0.05%+15.77%-32.83% 12.73B
Average -1.74%-0.97%+59.96%+83.01% 25.12B
Weighted average by Cap. -1.67%-1.36%+72.90%+112.72%

Financials

2026 *2027 *
Net sales 1.21B 1.06B 979M 900M 1.7B 117B 1.73B 11.7B 4.59B 57B 4.54B 4.44B 196B 1.26B 1.11B 1.02B 942M 1.78B 122B 1.81B 12.25B 4.8B 59.65B 4.75B 4.64B 206B
Net income 185M 162M 150M 138M 260M 17.81B 264M 1.79B 701M 8.71B 694M 678M 30.02B 220M 193M 178M 164M 309M 21.19B 314M 2.13B 835M 10.37B 825M 807M 35.73B
Net Debt -68.42M -59.97M -55.44M -50.98M -96.2M -6.6B -97.74M -663M -260M -3.23B -257M -251M -11.12B -352M -309M -285M -263M -495M -33.98B -503M -3.41B -1.34B -16.62B -1.32B -1.29B -57.28B
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
Date Price Change Volume
20/07/26 USD 71.64 -0.67% 3,217,135
17/07/26 USD 72.12 +0.49% 3,076,479
16/07/26 USD 71.77 +0.41% 3,424,545
15/07/26 USD 71.48 +0.35% 3,187,304
14/07/26 USD 71.23 -0.18% 3,000,988
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
71.64USD
Average target price
70.00USD
Spread / Average Target
-2.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TECH Stock